- Home
- / APIM Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
APIM Therapeutics financials data including stock price, CreditSafe score, income statement, and balance sheet.
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| NOK | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Cost of goods sold | 1.8M | 2.6M | 1.2M |
| Gross profit | (1.8M) | (2.6M) | (1.2M) |
| General and administrative expense | 1.0M | 1.9M | 1.8M |
| Operating expense total | 4.7M | 9.6M | 13.6M |
| EBIT | (6.5M) | (12.3M) | 14.8M |
| Interest income | 218.7K | 316.8K | 426.5K |
| Interest expense | 87.0 | 361.1K | |
| Pre tax profit | (6.3M) | (11.8M) | (14.8M) |
| Net Income | (6.3M) | (11.8M) | (14.8M) |